IGF-I Receptor and Gene Expression During the Cell Cycle

  • Renato Baserga
  • Christian Sell
  • Mitsuo Yoshinouchi
  • Krzysztof Reiss
  • Pierluigi Porcu
  • Hansjuerg Alder
  • Zbigniew Pietrzkowski
Conference paper
Part of the Serono Symposia, USA book series (SERONOSYMP)


This chapter discusses the pivotal role that the insulin-like growth factor I receptor (IGF-I-R) plays in the control of cellular proliferation in a variety of cell types.


Epidermal Growth Factor Receptor HL60 Cell WI38 Cell Exogenous Growth Factor Human Erythroleukemia Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Van Wyk JJ, Underwood LE, D’Ercole AJ, et al. Role of somatomedin in cellular proliferation. In: The biology of normal human growth. New York: Raven Press, 1981; 223–39.Google Scholar
  2. 2.
    Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts CR Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 1989; 86: 7451–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Kozak RW, Haskell JF, Greenstein LA, Rechler MM, Waldman TA, Nissley SP. Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cell Immunol 1987; 1009: 318–31.CrossRefGoogle Scholar
  4. 4.
    Hizuka N, Sukegawa I, Takano K, et al. Characterization of insulin-like growth factor I receptors on human erythroleukemia cell line (K-562 cells). Endocrinol Jpn 1987; 34: 81–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Lee PDK, Rosenfeld RG, Hintz RL, Smith SD. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 1986; 62: 28–35.PubMedCrossRefGoogle Scholar
  6. 6.
    Pepe MG, Ginzton NH, Lee PDK, Hintz RL, Greenberg P. Receptor binding and mitogenic effects of insulin and insulin-like growth factors I and II for human myeloid leukemic cells. J Cell Physiol 1987; 133: 219–27.PubMedCrossRefGoogle Scholar
  7. 7.
    Hartman W, Hitzler H, Schlickenrieder JHM, et al. Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublines. Leukemia 1988; 2: 241–4.Google Scholar
  8. 8.
    Goldring MB, Goldring SR. Cytokines and cell growth control. Eukar Gene Express 1991; 1: 301–26.Google Scholar
  9. 9.
    Stewart AJ, Johnson MD, May FEB, Westley BR. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172–8.PubMedGoogle Scholar
  10. 10.
    Pekonen F, Partanen S, Makinen T, Rutanen EM. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 1988; 48: 1343–7.PubMedGoogle Scholar
  11. 11.
    Peyrat JP, Bonneterre J, Beuscart R, Djiane J, Demaille A. Insulin-like growth factor I receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Res 1988; 48: 6429–33.PubMedGoogle Scholar
  12. 12.
    Foekens JA, Portengen H, van Puten WLJ, et al. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res 1989; 49: 5823–8.PubMedGoogle Scholar
  13. 13.
    Jaques G, Kiefer P, Rotsch M, et al. Production of insulin-like growth factor binding proteins by small-cell lung cancer cell lines. Exp Cell Res 1989; 184: 396–406.PubMedCrossRefGoogle Scholar
  14. 14.
    Minuto F, Del Monte P, Barreca A, Alama A, Cariola G, Giordano G. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line. Cancer Res 1988; 48: 3716–9.PubMedGoogle Scholar
  15. 15.
    Nakanishi Y, Mulshine J, Kasprzyk PG, et al. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988; 82: 354–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Ritvos O, Rutanen EM, Pekonen F, Jalkanen J, Suikkari AM, Ranta T. Characterization of functional type I insulin-like growth factor receptors from human choriocarcinoma cells. Endocrinology 1988; 122: 395–401.PubMedCrossRefGoogle Scholar
  17. 17.
    Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E. Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 1988; 48: 1233–7.PubMedGoogle Scholar
  18. 18.
    Pekonen F, Partanen S, Rutaenane EM. Binding of epidermal growth factor and insulin-like growth-factor I in renal carcinoma and adjacent normal kidney tissue. Int J Cancer 1989; 43: 1029–33.PubMedCrossRefGoogle Scholar
  19. 19.
    Talavera F, Reynolds RK, Roberts JA, Menon KM. Insulin-like growth factor I receptors in normal and neoplastic human endometrium. J Cancer Res 1990; 50: 3019–24.Google Scholar
  20. 20.
    Stracke ML, Engel JD, Wilson LW, Rechler MM, Liotta LA, Schiffman E. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. J Biol Chem 1989; 264: 21544–9.PubMedGoogle Scholar
  21. 21.
    Ota A, Shen-Orr Z, Roberts CT Jr, LeRoith D. TPA-induced neurite formation in a neuroblastoma cell line (SH-SY5Y) is associated with increased IGF-I receptor mRNA and binding. Mol Brain Res 1989; 6: 69–76.PubMedCrossRefGoogle Scholar
  22. 22.
    Ota A, Wilson GL, LeRoith D. Insulin-like growth factor I receptors on mouse neuroblastoma cells: two beta subunits are derived from differences in glycosylation. Eur J Biochem 1988; 174: 521–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Scher CD, Shephard RC, Antoniades HN, Stiles CD. Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochem Biophys Acta 1979; 560: 217–41.PubMedGoogle Scholar
  24. 24.
    Stiles CD, Capone GT, Scher CD, Antoniades NH, Van Wyk JJ, Pledger WJ. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 1979; 76: 1279–83.PubMedCrossRefGoogle Scholar
  25. 25.
    Leof EB, Wharton W, Van Wyk JJ, Pledger WJ. Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c3T3 cells. Exp Cell Res 1982; 141: 107–15.PubMedCrossRefGoogle Scholar
  26. 26.
    Russell WE, Van Wyk JJ, Pledger WJ. Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci USA 1984; 81: 2389–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Gai XX, Rizzo MG, Lee J, Ullrich A, Baserga R. Abrogation of the requirements for added growth factors in 3T3 cells constitutively expressing the p53 and IGF-I genes. Oncogene Res 1988; 3: 377–86.PubMedGoogle Scholar
  28. 28.
    Cherington PV, Smith BL, Pardee AB. Loss of epidermal growth factor requirement and malignant transformation. Proc Natl Acad Sci USA 1979; 76: 3937–41.PubMedCrossRefGoogle Scholar
  29. 29.
    Phillips PD, Cristofalo VJ. Classification system based on the functional equivalency of mitogens that regulate WI-38 cell proliferation. Exp Cell Res 1988; 175: 396–403.PubMedCrossRefGoogle Scholar
  30. 30.
    Armelin HA, Armelin MCS, Kelly K, et al. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature (London) 1984; 310: 655–60.CrossRefGoogle Scholar
  31. 31.
    Kaczmarek L, Hyland J, Watt R, Rosenberg R, Baserga R. Microinjected cmyc as a competence factor. Science 1985; 228: 1313–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Kaczmarek L, Surmacz E, Baserga R. Cycloheximide or puromycin can substitute for PDGF in inducing cellular DNA synthesis in quiescent 3T3 cells. Cell Biol Int Rep 1986; 10: 455–63.PubMedCrossRefGoogle Scholar
  33. 33.
    Praeger FC, Cristofalo VJ. The growth of WI-38 cells in a serum-free, growth factor-free, medium with elevated calcium concentrations. In Vitro 1986; 22: 355–9.Google Scholar
  34. 34.
    Travali S, Reiss K, Ferber A, et al. Constitutively expressed c-myb abrogates the requirement for insulin-like growth factor 1 in 3T3 fibroblasts. Mol Cell Biol 1991; 11: 731–6.PubMedGoogle Scholar
  35. 35.
    Clemmons DR, Shaw DS. Variables controlling somatomedin production by cultured human fibroblasts. J Cell Physiol 1983; 115: 137–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Clemmons DR, Van Wyk JJ. Somatomedin: physiological control and effect on cell proliferation. In: Baserga R, ed. Tissue growth factors. Berlin: Springer-Verlag, 1981: 161–208.CrossRefGoogle Scholar
  37. 37.
    Pietrzkowski Z, Lammers R, Carpenter G, et al. Constitutive expression of IGF-I and IGF-I receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ (in press).Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1993

Authors and Affiliations

  • Renato Baserga
  • Christian Sell
  • Mitsuo Yoshinouchi
  • Krzysztof Reiss
  • Pierluigi Porcu
  • Hansjuerg Alder
  • Zbigniew Pietrzkowski

There are no affiliations available

Personalised recommendations